Inloggad som:
MK-2870-005
Är du som patient intresserad av mer information om en studie, kontakta din behandlande läkare.
MK-2870-005
A Phase 3, Randomized, Active-controlled, Open-label, Multicenter Study to Compare the Efficacy and Safety of MK-2870 Monotherapy Versus Treatment of Physician’s Choice in Participants with Endometrial Cancer Who Have Received Prior Platinum-based Chemotherapy and Immunotherapy
A Phase 3, Randomized, Active-controlled, Open-label, Multicenter Study to Compare the Efficacy and Safety of MK-2870 Monotherapy Versus Treatment of Physician’s Choice in Participants with Endometrial Cancer Who Have Received Prior Platinum-based Chemotherapy and Immunotherapy
PLACEHOLDER
Randomisering mellan MK2870 eller läkaren val till patienter med endometriecancer som har återfall efter både platinumbaserad cytostatika och immunterapi
Mer information om studien för vårdgivare
Studien ändrades senast av: studyjohanna (2024-08-26)